Literature DB >> 16498164

Best evidence topic report. Intravenous magnesium in shock-resistant tachyarrhythmias.

Ayan Sen1, Shweta Gidwani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16498164      PMCID： PMC2464414          DOI： 10.1136/emj.2006.034694

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


× No keyword cloud information.
  5 in total

1.  Magnesium in cardiac arrest (the magic trial).

Authors:  D M Fatovich; D A Prentice; G J Dobb
Journal:  Resuscitation       Date:  1997-11       Impact factor: 5.262

2.  Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting.

Authors:  J Allegra; R Lavery; R Cody; G Birnbaum; J Brennan; A Hartman; M Horowitz; A Nashed; M Yablonski
Journal:  Resuscitation       Date:  2001-06       Impact factor: 5.262

3.  Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.

Authors:  M C Thel; A L Armstrong; S E McNulty; R M Califf; C M O'Connor
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

4.  A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation.

Authors:  T B Hassan; C Jagger; D B Barnett
Journal:  Emerg Med J       Date:  2002-01       Impact factor: 2.740

5.  Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies.

Authors:  B Miller; L Craddock; S Hoffenberg; S Heinz; D Lefkowitz; M L Callender; C Battaglia; C Maines; D Masick
Journal:  Resuscitation       Date:  1995-08       Impact factor: 5.262
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.